Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Colorectal Cancer
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Condition: Intestinal Abnormalities
Intervention: Device: PillCam SB2
Sponsor: Given Imaging Ltd.
Recruiting - verified March 2010
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBW 2992; Drug: Investigator´s choice of chemotherapy
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Conditions: Type 2 Diabetes; Morbid Obesity
Intervention:
Sponsor: University Hospital, Gasthuisberg
Recruiting - verified March 2010
Condition: HIV-1
Intervention: Biological: MYM-V101
Sponsors: Mymetics Corporation; Kinesis Pharma; CEVAC; M.A.R.C.O.; Mouton's Safety Consultancy; Pharmafour; Pevion; Chimera; Institute Cochin; San Raffaelle Hospital, Milan; INSERM UMR 721
Active, not recruiting - verified October 2009
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Mek Inhibitor MSC1936369B; Drug: Mek Inhibitor MSC1936369B; Drug: Placebo; Drug: FOLFIRI
Sponsor: EMD Serono
Recruiting - verified March 2010
Condition: Multifollicular Stimulation
Intervention: Drug: Recombinant-follicle stimulating hormone (r-FSH)
Sponsor: Merck KGaA
Active, not recruiting - verified March 2010
Condition: Haematological Malignancies
Interventions: Drug: AS703569; Drug: AS703569
Sponsor: EMD Serono
Active, not recruiting - verified March 2010
Condition: Smoking Cessation
Interventions: Behavioral: breathing technique; Behavioral: behavioral strategies
Sponsor: University Hospital, Ghent
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Inflammation
Intervention: Biological: LPS
Sponsor: Centre Hospitalier Universitaire Brugmann
Active, not recruiting - verified March 2010
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis
Intervention: Biological: HUMIRA (adalimumab)
Sponsors: Abbott; Veeda Clinical Research, Brussels
Recruiting - verified March 2010
Condition: Coxarthrosis
Intervention: Drug: Corticosterone
Sponsor: University Hospital Pellenberg
Not yet recruiting - verified February 2010
Condition: Prostatic Neoplasm
Intervention: Drug: leuprolide (Lucrin/Lucrin-Tri-depot)
Sponsor: Abbott
Active, not recruiting - verified March 2010
Condition: Ovarian Cancer
Interventions: Drug: olaparib; Drug: paclitaxel; Drug: carboplatin
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: capecitabine [Xeloda]; Drug: oxaliplatin
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Conditions: Psoriasis; Atopic Dermatitis
Interventions: Behavioral: education on skin disease conditions; Behavioral: Stress-reduction techniques; Behavioral: Lifestyle factors and psycho-education; Other: no educational program
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Vitiligo
Interventions: Drug: topical tacrolimus treatment; Drug: topical pimecrolimus treatment; Drug: local mometasone furoate treatment; Drug: vaseline treatment
Sponsor: University Hospital, Ghent
Recruiting - verified March 2010
Conditions: Critically Ill; Intra-Abdominal Hypertension; Abdominal Compartment Syndrome; Acute Kidney Injury
Interventions: Procedure: CVVH; Procedure: ultrafiltration; Procedure: ultrafiltration control group
Sponsors: University Hospital, Ghent; Department of Critical Care Medicine ZNA Stuivenberg Hospital Antwerp Belgium; Department of Nephrology University Hospital Ghent Belgium
Recruiting - verified February 2010
Condition: Familial Hypercholesterolaemia
Interventions: Drug: rosuvastatin calcium; Drug: rosuvastatin calcium; Drug: rosuvastatin calcium
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Transient Left Ventricular Ballooning Syndrome
Intervention:
Sponsor: University Hospital, Gasthuisberg
Not yet recruiting - verified December 2009
Condition: Mild Dementia
Intervention:
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Respiratory Failure
Interventions: Drug: dexmedetomidine; Procedure: Vital signs; Procedure: blood sampling
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Conditions: Squamous Cell Carcinoma of the Oral Cavity; Oropharynx Metastases; Lymph Metastases
Interventions: Procedure: endoscopic examination; Procedure: FDG-PET
Sponsor: University Hospital, Ghent
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Severe Respiratory Syncytial Virus Infection
Intervention:
Sponsor: Abbott
Completed - verified February 2010
Condition: Severe Aortic Valve Stenosis
Intervention: Device: Medtronic CoreValve System
Sponsor: Medtronic Bakken Research Center
Recruiting - verified March 2010
Conditions: Non Invasive Ventilation; Patient Ventilator Interaction
Intervention: Device: Neurally Adjusted Ventilatory Assist
Sponsors: University Hospital, Geneva; University Hospital St Luc, Brussels; University Hospital Sart Tilman, Liege; University of Lausanne Hospitals; Notre Dame de Grace Hospital, Gosselies
Not yet recruiting - verified January 2010
Condition: HCV Infection
Interventions: Drug: GS-9256; Drug: GS-9190; Drug: Ribavirin
Sponsor: Gilead Sciences
Recruiting - verified March 2010
Condition: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
Interventions: Other: questionnaires; Biological: blood sampling; Other: clinical evaluation; Other: Dermatology evaluation; Other: Bone evaluation
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Cancer
Intervention: Behavioral: mindfulness based stress reduction program
Sponsor: Belgian Federal Public Service, Food Chain Safety and Environment
Not yet recruiting - verified February 2010
Condition: Intra-Abdominal Hypertension
Intervention: Drug: furosemide
Sponsor: Ziekenhuis Netwerk Antwerpen (ZNA)
Recruiting - verified February 2010
Condition: Healthy
Interventions: Biological: CNTO 5825; Biological: CNTO 5825; Biological: CNTO 5825; Biological: CNTO 5825; Biological: CNTO 5825; Biological: CNTO 5825; Biological: CNTO 5825
Sponsor: Centocor, Inc.
Recruiting - verified March 2010
Condition: Chronic Constipation
Intervention: Drug: Prucalopride
Sponsor: Movetis
Completed - verified February 2010
Conditions: Breast Cancer; Bone Metastases
Intervention: Drug: Radium-223 chloride (Alpharadin)
Sponsor: Algeta ASA
Recruiting - verified March 2010
All Locations ... More Countries » ... Belgium 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
